COVID-19 Vaccine Uptake Amongst Underserved Populations in East London (NCT05866237) | Clinical Trial Compass
CompletedNot Applicable
COVID-19 Vaccine Uptake Amongst Underserved Populations in East London
United Kingdom5,903 participantsStarted 2023-11-28
Plain-language summary
This is a randomised controlled pilot study evaluating and assessing the feasibility of a co-designed PET. The PET was co-designed in the qualitative work packages with members of the community as well as healthcare professionals (Ethical approval: REF QMERC22.266) that precedes this pilot trial.
Eligible patients from six GP practises from Tower Hamlets and Newham will be randomised to the intervention or control during the study.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. non-white ethnicity OR
. resident in a postcode in the bottom 20% of index of multiple deprivation OR
. Those receiving little or no income
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study focused on COVID-19 and flu vaccine uptake in underserved communities in East London — does my background or situation mean there are specific barriers to vaccination my doctor should know about when helping me decide?
2Since this trial is now completed, has my doctor seen any results or findings about what actually helped people in similar situations choose to get vaccinated, and could those insights apply to me?
3The study looked at people who had previously refused or hesitated about vaccination — if that describes me, how does my doctor suggest we talk through those concerns together before I make a decision?
4Because this was a community-focused study rather than a drug or treatment trial, are there local support services or outreach programmes in my area that came out of this kind of research that my doctor could connect me with?
5Given that this trial measured vaccination uptake rather than testing a new vaccine or treatment, what does my doctor think is currently the best evidence for whether the COVID-19 or flu vaccines are right for my specific health situation?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The primary outcome is vaccination uptake in patients individually randomised.
Timeframe: Through study completion, until 6 months follow-up (>180 days since randomisation).